These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9652675)

  • 1. Can class I epitope of M protein be a diagnostic marker for rheumatic fever in populations endemic for group A streptococci?
    Brandt ER; Currie B; Mammo L; Pruksakorn S; Good MF
    Lancet; 1998 Jun; 351(9119):1860. PubMed ID: 9652675
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations.
    Brandt ER; Yarwood PJ; McMillan DJ; Vohra H; Currie B; Mammo L; Pruksakorn S; Saour J; Good MF
    Int Immunol; 2001 Oct; 13(10):1335-43. PubMed ID: 11581178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects of the etiology and pathogenesis of rheumatic fever].
    Rotta J
    Revmatologiia (Mosk); 1984; (1):62-6. PubMed ID: 6372012
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic epitope mapping of the M24 protein of Streptococcus pyogenes: implications for serodiagnosis of rheumatic fever.
    Norton RE; Heuzenroeder M; Manning PA
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):267-71. PubMed ID: 9116645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients.
    Bessen DE; Veasy LG; Hill HR; Augustine NH; Fischetti VA
    J Infect Dis; 1995 Dec; 172(6):1608-11. PubMed ID: 7594728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease.
    Thakur A; Singhal S; Prakash K
    J Med Microbiol; 1996 Dec; 45(6):483-9. PubMed ID: 8958254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatic fever.
    Stollerman GH
    Lancet; 1997 Mar; 349(9056):935-42. PubMed ID: 9093263
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteinuria is associated with persistence of antibody to streptococcal M protein in Aboriginal Australians.
    Goodfellow AM; Hoy WE; Sriprakash KS; Daly MJ; Reeve MP; Mathews JD
    Epidemiol Infect; 1999 Feb; 122(1):67-75. PubMed ID: 10098787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of group a streptococcal anti-M type-specific antibody in sera of rheumatic fever patients after 45 years.
    Bencivenga JF; Johnson DR; Kaplan EL
    Clin Infect Dis; 2009 Oct; 49(8):1237-9. PubMed ID: 19761409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vaccine against Streptococcus pyogenes: the potential to prevent rheumatic fever and rheumatic heart disease.
    Guilherme L; Ferreira FM; Köhler KF; Postol E; Kalil J
    Am J Cardiovasc Drugs; 2013 Feb; 13(1):1-4. PubMed ID: 23355360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.
    Brandt ER; Hayman WA; Currie B; Carapetis J; Jackson DC; Do KA; Good MF
    Int Immunol; 1999 Apr; 11(4):569-76. PubMed ID: 10323210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probable role of streptococcal antigens in patients of rheumatic fever & rheumatic heart disease.
    Prakash K; Bhatnagar PK
    Indian J Med Res; 1987 Sep; 86():347-50. PubMed ID: 3428969
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rheumatic fever--rheumatic carditis].
    Kawakita S; Iwamoto H
    Nihon Rinsho; 1973 Dec; 31(12):3402-8. PubMed ID: 4598900
    [No Abstract]   [Full Text] [Related]  

  • 15. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.
    Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF
    Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Streptococci, molecular mimicry and APO titer].
    Fantini F
    Boll Ist Sieroter Milan; 1989; 68(2):108-14. PubMed ID: 2491296
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions.
    Guilherme L; Faé KC; Oshiro SE; Tanaka AC; Pomerantzeff PM; Kalil J
    Ann N Y Acad Sci; 2005 Jun; 1051():132-40. PubMed ID: 16126952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatic fever and the streptococcus. Another look at molecular mimicry.
    Williams RC
    Am J Med; 1983 Nov; 75(5):727-30. PubMed ID: 6356912
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing epidemiology of acute rheumatic fever in the United States.
    Lee GM; Wessels MR
    Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.